Seeing Is Believing
RCEL is currently covered by 5 analysts with an average price target of $16.73. This is a potential upside of $8.16 (95.22%) from yesterday's end of day stock price of $8.57.
Avita Medical Ltd's activity chart (see below) currently has 14 price targets and 25 ratings on display. The stock rating distribution of RCEL is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 31.67% with an average time for these price targets to be met of 262.4 days.
Highest price target for RCEL is $40, Lowest price target is $21, average price target is $16.73.
Most recent stock forecast was given by RYAN ZIMMERMAN from BTIG on 11-Apr-2024. First documented stock forecast 31-Dec-2019.
Currently out of the existing stock ratings of RCEL, 16 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
19
14 days ago
2/4 (50%)
$3.57 (23.14%)
388
Buy
21
$12.43 (145.04%)
19
2 months 2 days ago
3/9 (33.33%)
$3.9 (22.81%)
211
Buy
25
$16.43 (191.72%)
22
2 months 2 days ago
0/7 (0%)
$7.9 (46.20%)
Buy
27
$18.43 (215.05%)
8 months 28 days ago
0/1 (0%)
$6.21 (29.87%)
Buy
40
$31.43 (366.74%)
12
9 months 12 days ago
3/4 (75%)
$19.21 (92.40%)
713
What is RCEL (Avita Medical Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on RCEL (Avita Medical Ltd) with a proven track record?
Which analyst has the current lower performing score on RCEL (Avita Medical Ltd) with a proven track record?
Which analyst has the most public recommendations on RCEL (Avita Medical Ltd)?
Which analyst is the currently most bullish on RCEL (Avita Medical Ltd)?
Which analyst is the currently most reserved on RCEL (Avita Medical Ltd)?